Stimcell Energetics, Inc.

0.4400+0.03 (+8.16%)
Oct 29, 4:00:00 PM EDT · OTC Markets OTCQB · STME · USD

Upcoming Earnings

Report date
≈ -

Key Stats

Market Cap
9.08M
P/E (TTM)
-
Basic EPS (TTM)
-0.04
Dividend Yield
0%

Recent Filings

About

StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions in the United States. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Cell MedX Corp. and changed its name to StimCell Energetics Inc. in November 2024. StimCell Energetics Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.

CEO
Mr. David M. Jeffs
IPO
8/29/2013
Sector
Healthcare
Industry
Medical Devices